CME Group Inc. (NASDAQ:CME) Shares Acquired by Longfellow Investment Management Co. LLC

Longfellow Investment Management Co. LLC lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 8,013.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,217 shares of the financial services provider’s stock after purchasing an additional 1,202 shares during the period. Longfellow Investment Management Co. LLC’s holdings in CME Group were worth $239,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Gold Investment Management Ltd. acquired a new stake in CME Group in the fourth quarter valued at approximately $26,000. Northwest Financial Advisors acquired a new stake in CME Group in the 4th quarter valued at $28,000. Salomon & Ludwin LLC purchased a new stake in CME Group in the 1st quarter worth $28,000. McClarren Financial Advisors Inc. raised its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares during the period. Finally, Asset Dedication LLC lifted its holdings in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the sale, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.4 %

Shares of NASDAQ CME traded down $0.99 during mid-day trading on Monday, reaching $219.51. 81,128 shares of the company’s stock were exchanged, compared to its average volume of 1,923,301. The firm has a market capitalization of $79.04 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 8.92 and a beta of 0.55. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80. The company’s 50-day moving average is $203.51 and its 200-day moving average is $207.54. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the company posted $2.30 EPS. Analysts expect that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be paid a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.10%. CME Group’s payout ratio is presently 52.33%.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Barclays upped their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and set a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $209.73.

Check Out Our Latest Stock Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.